Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced mutasynthesis studies on the natural α-pyrone antibiotic myxopyronin from Myxococcus fulvus.

Chembiochem : a European journal of chemical biology - 13 Apr 2015

Sahner J Henning, Sucipto Hilda, Wenzel Silke C, Groh Matthias, Hartmann Rolf W, Müller Rolf

Abstract excerpt

Myxopyronin is a natural α-pyrone antibiotic from the soil bacterium Myxococcus fulvus Mx f50. Myxopyronin inhibits bacterial RNA polymerase (RNAP) by binding to a part of the enzyme not targeted by the clinically used rifamycins. This mode of action makes myxopyronins promising molecules for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Biological Products
Share to DNA-Directed RNA Polymerases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Molecular

Share to Mutation

Share to Protein Conformation

Share to Pyrones

Share to Thermus thermophilus

Source

Identifiers

PMID: 25757034
DOI: 10.1002/cbic.201402666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25757034-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced mutasynthesis studies on the natural α-pyrone antibiotic myxopyronin from Myxococcus fulvus.PMID 25757034Read ↗

Mutational biosynthesis--a tool for the generation of structural diversity in the biosynthesis of antibiotics.Semantic proximity Read ↗

Ribosome engineering of Myxococcus xanthus for enhancing the heterologous production of epothilones.Semantic proximity Read ↗

Lost in Transcription—Inhibition of RNA PolymeraseSemantic proximity Read ↗

Discovery of 16-Demethylrifamycins by Removing the Predominant Polyketide Biosynthesis Pathway in Micromonospora sp. Strain TP-A0468Semantic proximity Read ↗

Myxobacteria: natural pharmaceutical factoriesSemantic proximity Read ↗

Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering.Semantic proximity Read ↗

Programmed Iteration Controls the Assembly of the Nonanoic Acid Side Chain of the Antibiotic MupirocinSemantic proximity Read ↗

Mutasynthesis - uniting chemistry and genetics for drug discovery.Semantic proximity Read ↗

A transposon-based strategy to scale up myxothiazol production in myxobacterial cell factories.Semantic proximity Read ↗

Bioinformatics-based stereochemical elucidation of MM 46115: an unusual antiviral spirotetronate that inhibits clathrin-mediated endocytosisSemantic proximity Read ↗

Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity.Semantic proximity Read ↗

Cyclic lipopeptide natural products as taxa-specific antibacterial inhibitors of the lipid II flippaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.